MENU
Articles by #hashtag

Hungarian Investment Promotion Agency (HIPA)

5 hits

Keeping Up Japanese Business Interest

Sándor Laczkó
Feb 28, 2022

Japan is the second most important investor country in Hungary from the Far East. The CEO of the Hungarian Investment Promotion Agency (HIPA), Róbert Ésik explains to Diplomacy&Trade how the organization is working to attract more Japanese investors and to accommodate those already established here helping the Hungarian economy. “One of the first large foreign […]

The Most Prominent Investors of 2020 in Hungary

D&T
Sep 8, 2021

2020 was also a special year for the Hungarian Investment Promotion Agency (HIPA). The organzation says that although operations were still normal at the beginning of the year, the pandemic that started in the spring brought about unprecedented challenges for both investors and the country at large. Despite the circumstances, HIPA contributed to the implementation […]

Counting on the German Investment Community

Sándor Laczkó
Mar 3, 2021

Germany is Hungary’s most important economic partner, the Hungarian economy highly relies on the ‘well-being’ of the German one. The CEO of the Hungarian Investment Promotion Agency (HIPA), Róbert Ésik explains to Diplomacy&Trade his agency’s role in attracting and maintaining German investment in this country. “From the foreign direct investment (FDI) point of view, Germany […]

Welcoming Korean investors to Hungary

Sándor Laczkó
Oct 6, 2020

Last year, the Republic of Korea was the largest source of foreign direct investments in Hungary. The Hungarian Investment Promotion Agency (HIPA) played a pivotal role in many of these investment projects as its CEO, Róbert Ésik explains to Diplomacy&Trade. He points out that 2019 was another successful year for Hungary in terms of foreign […]

Korean Ambassador Kyoo Sik Choe and Hungarian Minister for Foreign Affiars and Trade, Péter Szijjártó (on the left) at the announcement

Samyang Biopharm: First European Unit in Gödöllő

D&T
Jul 29, 2020

South Korea-based Samyang Biopharm, specializing in medical devices, has selected Hungary for its first production unit in Europe. The HUF 8.6 billion (EUR 26.2 million) unit, will produce synthetic suture materials and create 55 new jobs in Gödöllő. The Hungarian government contributes about 15% of that amount (HUF 1.3 billion) in non-refundable support. The South […]

© Copyright 2024 Duax Kft. –  All rights reserved.
sun